DIFFERENTIAL GLYCOSYLATION OF INTERLEUKIN 2, THE MOLECULAR BASIS FOR THE NOD Idd3 TYPE 1 DIABETES GENE?
- 1 May 2000
- Vol. 12 (5) , 477-482
- https://doi.org/10.1006/cyto.1999.0609
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Homeostasis and Self-Tolerance in the Immune System: Turning Lymphocytes offScience, 1998
- Genetic Control of Autoimmune Diabetes in the Nod MouseAnnual Review of Immunology, 1995
- Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes.The Journal of Experimental Medicine, 1994
- Responses of NOD Congenic Mice to a Glutamic Acid Decarboxylase-derived PeptideJournal of Autoimmunity, 1994
- Polygenic control of autoimmune diabetes in nonobese diabetic miceNature Genetics, 1993
- Interleukin-2Current Opinion in Immunology, 1992
- Unique structure of murine interleukin-2 as deduced from cloned cDNAsNature, 1985
- Molecular Characterization of Interleukin 2Immunological Reviews, 1982
- Heterogeneity of human T-cell growth factor(s) due to variable glycosylationMolecular Immunology, 1981
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970